AzTrials
AzTrials

Attention Deficit Disorder With HyperactivityMyBNCT03289793

NEUROFEEDBACK on Event-Related Potential (ERP)

A study testing Neurofeedback training in people with Attention Deficit Disorder With Hyperactivity, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project aims to assess the evolution of symptoms in ADHD children from 8 to 17 years, with various types of attention training. Different groups A, B and C will be evaluated: the first with Neurofeedback training, the second with a similar training but not indexed on brain activity and the third without training. Read more about this study

Who is it for?
Ages 8 to 17 years
What is being tested?
Neurofeedback training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
52 participants
Where
1 siteFrance
Study dates
2 Feb 2017to 9 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children and teenagers aged from 8 to 17 years' old
  • Children and teenagers with a deficit attention disorder with or without hyperactivity, in the mixed form or in a pure inattentive form according to Diagnostique et Statistique des troubles Mentaux (DSM)-V.
  • Children and teenagers having a score in Verbal Comprehension Index (or Index Verbal Reasoning) and Perceptual Reasoning Index (or Index Reasoning fluid) ≥ 80 of WISC IV or V test, not older than two years.
  • Children and teenagers without psychostimulant treatment
  • Children and teenagers with psychostimulant treatment agreed to achieve a therapeutic break at each visit day and with a stable dose during all the study.
  • Children and teenagers whose parents have agreed and signed informed consent form of the study.

Who cannot join

  • Children aged less than 8 and teenagers are more than 18 years' old.
  • Children and teenagers having a score in Verbal Comprehension Index (or Index Verbal Reasoning) and Perceptual Reasoning Index (or Index Reasoning fluid) < 80 of WISC IV or V test, not older than two years.
  • Children and teenagers with developmental disorder except "Dys" disorders.
  • Children and teenagers with pure hyperactivity (without attentional deficit)
  • Children and teenagers with epilepsy except benign epilepsies (without brain damage), free of crisis for two years and without treatment.
  • Children and teenagers with ADHD with conduct disorders and aggression
Show all 10Show fewer
  • Children and teenagers with ADHD and Tourette's syndrome.
  • Patients treated by anti / epilepsy or psychotropic treatments (with the exception of psychostimulant treatment).
  • Patients with psychostimulant treatment and whose parents aren't agreed to achieve a therapeutic break at each visit day.
  • Patients with visual deficiency uncorrectable with lenses or glasses.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hospices Civils de Lyon

    Bron, 69500

Other trials in France

About this study

Official title: Clinical Evaluation of a Brain Computer Interfaces (BCI)-Based Training of Attention in Children With Attention Deficit Hyperactivity Disorder (ADHD)

This project aims to assess the evolution of symptoms in ADHD children from 8 to 17 years, with various types of attention training.

Different groups A, B and C will be evaluated: the first with Neurofeedback training, the second with a similar training but not indexed on brain activity and the third without training.

Read more

30 patients will be randomly assigned to groups A and B according to a ratio 2:1.

Others patients who meet the same criteria but for logistical reasons cannot comply with the training constraints will be assigned to group C.

Children included in groups A and B will participate in training sessions (Neurofeedback and control training, respectively) as well as in four evaluation sessions. Children in group C will only participate in evaluation sessions (baseline control group).

Patients of groups A and B will be followed over 6 months: 4 months of training and a follow-up evaluation 2 months after training.

Patients of group C will be followed each 2 months for 6 months. This study uses electro-encephalography measures, serious video game, neuropsychological tests and questionnaires.

It also uses actigraphy measures to evaluate sleep quality.

Being tested
Neurofeedback training, Active Sham control, Baseline control group
Keywords
Attention Deficit Disorder with Hyperactivity, ADHD, Children, Inattention, Hyperactivity, Neurofeedback, Neuropsychology
Medical subject headings
Attention Deficit Disorder with Hyperactivity, Spasm

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neurofeedback trainingOther

    Children in group A will receive BCI-based training implemented through original P300-based controlled games.

    They will attend 30 1-hour long training sessions at a pace of 2 sessions per week.

    Each session includes: installation of the child, the EEG system and an eye-tracking system, a 5-minutes relaxation phase, a short EEG recording at rest, a brief reminder of the instructions, 30 minutes of training by playing video games and finally a time for the child to wash her/his hair.

    Moreover, 4 neuropsychological sessions will complement the 30 training sessions. During these sessions neuropsychological tests and quality of life questionnaires will be answered.

  • Active Sham controlOther

    Children in group B will receive a training that is not based on brain activity, but in a blind fashion. They will attend 30 1-hour long training sessions at a pace of 2 sessions per week.

    Each session includes: installation of the child, setting up the EEG and eye-tracking systems, a 5-minutes relaxation phase, short EEG recording at rest, a brief reminder of the instructions, 30 minutes of video game based training and finally a time for the child to wash her/his hair.

    Besides, 4 neuropsychological sessions will complement the 30 training sessions. During these sessions neuropsychological tests and quality of life questionnaires will be performed.

  • Baseline control groupOther

    The children included in this group will not receive any training. They only take part to the 4 neuropsychological sessions. Like others, they will attend 1 neuropsychological session every two months over six months.

Study groups in NCT03289793
Study groupRoleWhat they receive
Group AExperimentalChildren will be assigned to this group in a random fashion according to a ratio 2:1 with respect to group B (see below). 20 subjects will be included in this group.
Receives: Other: Neurofeedback training
Group BActive comparatorChildren will be assigned in this group in a random fashion. 10 subjects will be included in this group.
Receives: Other: Active Sham control
Group CActive comparatorWill be included in this group children who meet the inclusion criteria and who, with their families, are motivated to participate in the study but cannot claim to be part of groups A or B (because of logistical constraints: living too far away to comply with the frequency of the visits required by the training). Group C allows to follow the natural evolution of children with ADHD with no intervention.
Receives: Other: Baseline control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of the relative effect on symptoms of inattention between the two proposed training techniques, A and B, with the ADHD Rating Scale in children with ADHD

    Questions with odd numbers interested in the dimension "inattentive" will particularly be studied. The investigator expect an improvement in the type of score: ''ADHD-Inattentive'' children in group A compared to children in Group B. More specifically, he expect to improve responses to questions number 1,3,5,7,9,11,13,15 and 17. By definition, an evolving response would be to move from " 2=Often; 3=Very often" to " 1=Sometimes; 0=Rarely/Never".

    Measured: every two months over six months.

Secondary outcomes (59)
  1. Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children

    ADHD Rating Scale (questions with odd numbers) will be performed ADHD children from groups A, B and C will be compared

    Measured: every months over six months.

  2. Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children

    Bron/Lyon Attention Stability test (BLAST) test will be performed ADHD children from groups A, B and C will be compared

    Measured: every months over six months.

  3. Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children

    Wechsler Intelligence Scale for Children (WISC) subtests will be performed ADHD children from groups A, B and C will be compared

    Measured: every months over six months.

  4. Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children

    Wechsler Intelligence Scale for Children (WISC) will be performed ADHD children from groups A, B and C will be compared

    Measured: every months over six months.

  5. Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children

    ADHD Rating Scale (questions with odd numbers) will be performed ADHD children from groups A, B and C will be compared

    Measured: every months over six months.

  6. Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children

    Bron/Lyon Attention Stability test (BLAST) will be performed ADHD children from groups A, B and C will be compared

    Measured: every months over six months.

  7. Compare the effects of the two types of trainings on the hyperactivity symptoms in ADHD children using neuropsychological assessments.

    ADHD Rating Scale (questions with even numbers), Test d'évaluation de l'Attention (TAP) and Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  8. neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children

    ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  9. neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children

    Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  10. neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children

    Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  11. neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children

    Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  12. neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children

    Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  13. neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children

    ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  14. neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children

    Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  15. neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children

    ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  16. neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children

    Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared

    Measured: every two months over six months

  17. Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  18. Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    TAP will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  19. Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    CPT will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  20. Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    BLAST will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  21. Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  22. Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    ADHD Rating Scale (questions with odd numbers)will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  23. Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    TAP will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  24. Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    CPT will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  25. Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    BLAST will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  26. Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  27. Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  28. Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    TAP will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  29. Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    CPT will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  30. Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    BLAST will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  31. Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.

    Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  32. Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP))

    ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  33. Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP))

    TAP will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  34. Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP))

    BLAST will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  35. Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP))

    Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  36. Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  37. Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    TAP will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  38. Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    BLAST will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  39. Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  40. Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR)

    ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  41. Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR)

    TAP will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  42. Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR)

    BLAST will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  43. Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR)

    Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  44. Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  45. Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    TAP will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  46. Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    BLAST will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  47. Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  48. Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR)

    ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  49. Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR)

    TAP will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  50. Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR)

    BLAST will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  51. Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR)

    Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  52. Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    ADHD Rating Scale (questions with odd numbers)will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  53. Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    TAP will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  54. Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    BLAST will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  55. Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.

    Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared

    Measured: every two months over six months

  56. Evaluate the impact of the trainings on the sleep quality in ADHD children.

    Sleep questionnaires will be distributed ADHD children in groups A, B and C will be compared.

    Measured: every two months over six months.

  57. Evaluate the impact of the trainings on the sleep quality in ADHD children.

    The sleep data may also be collected using an actigraph (ancillary study). ADHD children in groups A, B and C will be compared.

    Measured: every two months over six months.

  58. Evaluating the impact of the trainings on the quality of life in ADHD children.

    The Child Behavior CheckList (CBCL) questionnaire will be performed

    Groups A, B and C will be compared.

    Measured: every two months over six months

  59. Evaluating the impact of the trainings on the quality of life in ADHD children.

    Information about the quality of life will be also collected in a logbook by family members and provided at each visit.

    Groups A, B and C will be compared.

    Measured: every two months over six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2017
  2. Study start2 Feb 2017
  3. Primary completion9 Sep 2019
  4. Study completion9 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03289793
Sponsor's protocol ID
69HCL15_0214
Acronym
MyB
Status last verified
Oct 2019
First submitted
4 Aug 2017
Last updated
29 Oct 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Neurofeedback training in people with Attention Deficit Disorder With Hyperactivity, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of the relative effect on symptoms of inattention between the two proposed training techniques, A and B, with the ADHD Rating Scale in children with ADHD (time frame: every two months over six months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in